Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00656_DB01211_nanopub.RAGtR6N1gMNeSF_vRERtU78juEuT6YApCrwO72G1Nor5Q#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00656_DB01211 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00656_DB01211 label "DDI between Trazodone and Clarithromycin - The CYP3A4 inhibitor, Clarithromycin, may increase Trazodone efficacy/toxicity by decreasing Trazodone metabolism and clearance. Consider alternate therapy or monitor for changes in Trazodone efficacy/toxicity if Clarithromycin is initiated, discontinued or dose changed. [drugbank_resource:DB00656_DB01211]" assertion.
- drugbank_resource:DB00656_DB01211 identifier "drugbank_resource:DB00656_DB01211" assertion.
- drugbank_resource:DB00656_DB01211 title "DDI between Trazodone and Clarithromycin - The CYP3A4 inhibitor, Clarithromycin, may increase Trazodone efficacy/toxicity by decreasing Trazodone metabolism and clearance. Consider alternate therapy or monitor for changes in Trazodone efficacy/toxicity if Clarithromycin is initiated, discontinued or dose changed." assertion.
- drugbank:DB01211 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00656_DB01211 assertion.
- drugbank:DB00656 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00656_DB01211 assertion.